JP2006028070A - Antineoplastic composition - Google Patents

Antineoplastic composition Download PDF

Info

Publication number
JP2006028070A
JP2006028070A JP2004207988A JP2004207988A JP2006028070A JP 2006028070 A JP2006028070 A JP 2006028070A JP 2004207988 A JP2004207988 A JP 2004207988A JP 2004207988 A JP2004207988 A JP 2004207988A JP 2006028070 A JP2006028070 A JP 2006028070A
Authority
JP
Japan
Prior art keywords
hot water
himematsutake
water extract
cell wall
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004207988A
Other languages
Japanese (ja)
Inventor
Hitoshi Ito
均 伊藤
Fukuyoshi Nakada
福佳 中田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAWAFURU KENKO SHOKUHIN KK
Original Assignee
PAWAFURU KENKO SHOKUHIN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAWAFURU KENKO SHOKUHIN KK filed Critical PAWAFURU KENKO SHOKUHIN KK
Priority to JP2004207988A priority Critical patent/JP2006028070A/en
Publication of JP2006028070A publication Critical patent/JP2006028070A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an antineoplastic composition having high safety and antineoplastic activity. <P>SOLUTION: The antineoplastic composition comprises a hot water extract of Agaricus blazei Murrill and a bovine globulin concentrate. Specifically, the hot water extract is obtained from either one of the following: the carpophore, its cell wall broken product, cultured product, its cell wall broken product of Agaricus blazei Murrill and dried products thereof. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、ハラタケ属(Agaricus)のキノコである「学名」Agaricus blazei Murrill「正式和名」ヒメマツタケ(一名、カワリハラタケ)の抽出物と牛グロブリン濃縮物とを必須成分とした抗腫瘍作用に優れた抗腫瘍組成物に関する。   The present invention has an excellent antitumor effect comprising an extract of "A scientific name" Agaricus blazei Murrill "official Japanese name" Himematsutake (one name, Kawariharatake) and bovine globulin concentrate, which are mushrooms of the genus Agaricus (Agaricus). Relates to antitumor compositions.

抗腫薬は、がん細胞の増殖阻止作用をもつ薬物で、増殖に必要な核酸や蛋白質の合成を直接阻害することで作用を発現する細胞毒性薬と、免疫機構を介して間接的に阻害する生物学的応答調節物質(BRM)がある。   Antitumor drugs are drugs that inhibit the growth of cancer cells, and are indirectly inhibited through the immune mechanism and cytotoxic drugs that exert their effects by directly inhibiting the synthesis of nucleic acids and proteins required for growth. Biological response modifiers (BRMs).

BRMに分類されるヒメマツタケについては、当該本発明者の一人、伊藤均らにより1980年日本癌学会総会で報告されたのが契機であり、すでに公的学会・学術誌に60報余の発表がされている(例えば、特許文献1〜3参照)。
しかし、有害作用のない細胞毒性薬はなく、作用機序の異なる複数の抗腫瘍薬を少量ずつ組合せることにより、有害作用の軽減をはかりつつ、有効性を高める多剤併用療法が行われる。
As for the Japanese matsutake mushrooms classified as BRM, one of the inventors of the present invention, Hitoshi Ito, was reported at the 1980 general meeting of the Japanese Cancer Association, and more than 60 publications have already been published in public societies and academic journals. (For example, see Patent Documents 1 to 3).
However, there is no cytotoxic drug having no adverse effect, and a multi-drug combination therapy is carried out to increase the effectiveness while reducing the adverse effect by combining a plurality of antitumor drugs having different action mechanisms one by one.

そこで、いわゆるBRMに属するキノコ類、海藻類、クマ笹、ローヤルゼリー、サメ軟骨、人参、十全大補湯などの漢方方剤の単独及び併用、さらに細胞毒性薬とBRMとの併用が一般的に行なわれる。しかし、安全性と抗腫瘍作用について未だ十分に満足の行くものが得られていなかったのが実状であった。
特開昭64−67194号公報 特開昭64−67195号公報 特開平2−78630号公報
Therefore, generally used are Chinese medicines such as mushrooms, seaweeds, bear moths, royal jelly, shark cartilage, carrots, Juzentaihoto, etc. belonging to the so-called BRM, and combined use of cytotoxic drugs and BRM. Done. However, the actual situation is that satisfactory safety and antitumor effects have not yet been obtained.
JP-A 64-67194 JP-A 64-67195 JP-A-2-78630

本発明は、斯かる従来の実状に鑑みてなされたものであり、優れた安全性と抗腫瘍作用を有する組成物を提供することを課題とする。   This invention is made | formed in view of such the conventional actual condition, and makes it a subject to provide the composition which has the outstanding safety | security and antitumor action.

本発明は、ヒメマツタケの熱水抽出物と牛グロブリン濃縮物とを含有することを特徴とする抗腫瘍組成物により上記課題を解決したものである。   This invention solves the said subject with the anti-tumor composition characterized by including the hot-water extract of Japanese matsutake and a cow globulin concentrate.

本発明組成物は、毒性がなく安全性に優れ、しかも高い抗腫瘍作用を有するので、経口投与により腫瘍の抑制、治療を効果的に行なうことができる。   Since the composition of the present invention has no toxicity, is excellent in safety, and has a high antitumor action, it can effectively suppress and treat tumors by oral administration.

本発明において、ヒメマツタケの熱水抽出物は、ヒメマツタケの子実体、ヒメマツタケ培養物、ヒメマツタケの子実体の細胞壁破壊物、ヒメマツタケ培養物の細胞壁破壊物、それらの乾燥物の何れか1種以上から得られるが、保存性、取扱性及び抽出効率の点で当該乾燥物から抽出するのが好ましい。   In the present invention, a hot water extract of Himematsutake is obtained from any one or more of Himematsutake fruiting bodies, Himematsutake cultures, cell wall destruction products of Himematsutake fruiting bodies, cell wall destruction products of Himematsutake cultures, and dried products thereof. However, it is preferable to extract from the dried product in terms of storage stability, handleability and extraction efficiency.

本発明において、熱水抽出に先立ち、ヒメマツタケの子実体やヒメマツタケ培養物、あるいはそれらの細胞壁破壊物やそれらの乾燥物を有機溶媒又は含水有機溶媒で抽出処理して、これらに特有の臭気成分や色素成分を除去しておくのが望ましい。ここに用いる有機溶媒としてはメタノール、エタノール、酢酸エチル、エーテル等があり、また含水有機溶媒としては一般に30%以下の範囲で水を含有する含水メタノール、含水エタノール等があるが、取扱性及び残留有機溶媒の点で80%程度のエタノールが好ましい。   In the present invention, prior to the hot water extraction, the fruit bodies of Japanese matsutake, himematsutake culture, or their cell wall destruction products and their dried products are extracted with an organic solvent or a water-containing organic solvent, and odor components peculiar to these It is desirable to remove the pigment component. The organic solvent used here includes methanol, ethanol, ethyl acetate, ether, and the like, and the water-containing organic solvent generally includes water-containing methanol, water-containing ethanol, etc. in a range of 30% or less. About 80% ethanol is preferred in terms of organic solvent.

また、本発明の熱水抽出物としては、熱水抽出液、その減圧濃縮液あるいはその凍結乾燥物の何れであっても良いが、熱水抽出液を減圧濃縮し、次いでエタノールで沈澱処理し、次いで液体クロマトグラフィーで分画処理し、次いで透析した後、凍結乾燥したものが望ましい。   The hot water extract of the present invention may be any one of a hot water extract, a vacuum concentrated solution thereof, or a lyophilized product thereof. The hot water extract is concentrated under reduced pressure, and then subjected to a precipitation treatment with ethanol. Then, it is desirable to perform fractionation by liquid chromatography, followed by dialysis and lyophilization.

因に、ヒメマツタケの子実体の細胞壁破壊乾燥物をその倍量の熱水で2時間抽出し、その熱水抽出液を更に減圧濃縮、液体クロマトグラフィーによる分画、透析及び凍結乾燥して得られる抽出物は、その一例を挙げると、次のような化学的組成を有する。粗灰分5.36%(重量%、以下同じ)、粗蛋白41.20%、粗脂質3.54%、粗繊維6.20%、糖質43.57%、エルゴステロール0.13%。これらの粗灰分、粗蛋白、粗脂質及び糖質は、更に分析すると、それぞれ表1、表2、表3及び表4の組成を有する。   In addition, the cell wall-disrupted dried material of the fruit body of Himematsutake is extracted with double the amount of hot water for 2 hours, and the hot water extract is further concentrated under reduced pressure, fractionated by liquid chromatography, dialysis and freeze-dried. For example, the extract has the following chemical composition. Crude ash content 5.36% (wt%, the same applies hereinafter), crude protein 41.20%, crude lipid 3.54%, crude fiber 6.20%, carbohydrate 43.57%, ergosterol 0.13%. When these crude ash, crude protein, crude lipid and carbohydrate are further analyzed, they have the compositions of Table 1, Table 2, Table 3 and Table 4, respectively.

Figure 2006028070
Figure 2006028070

Figure 2006028070
Figure 2006028070

Figure 2006028070
Figure 2006028070

Figure 2006028070
Figure 2006028070

上記のような組成を有する抽出物は一定の分解点、融点を示さず、強熱により炭化するが、著しく安定である。室温では少なくとも3年間は安定であり、120℃×20分間の滅菌処理を行なっても活性の低下は見られない。   An extract having the above composition does not exhibit a certain decomposition point and melting point, and is carbonized by ignition, but is extremely stable. It is stable at room temperature for at least 3 years, and no decrease in activity is observed even after sterilization at 120 ° C. for 20 minutes.

牛グロブリン濃縮物は、アメリカ農務省の指定するGMP規準に合致した高純度品用施設で、食用牛の血清から精製された100%天然品であり、保存性が高く安定である。牛グロブリン濃縮物の成分を表5に示す。この数値は、米国プロライアント社のデータである。   Bovine globulin concentrate is a 100% natural product purified from the serum of edible cattle at a facility for high-purity products that meets the GMP standards specified by the US Department of Agriculture, and is highly stable and stable. The ingredients of the bovine globulin concentrate are shown in Table 5. This figure is data from Proliant USA.

Figure 2006028070
Figure 2006028070

本発明組成物中には、上記の如きヒメマツタケの熱水抽出物と牛グロブリン濃縮物が配合されるが、両者の配合割合は、前者1質量部に対し、後者0.5〜20質量部とするのが好ましい。   In the composition of the present invention, the hot water extract of Japanese matsutake and the beef globulin concentrate as described above are blended, and the blending ratio of both is 0.5 to 20 parts by mass of the latter with respect to 1 part by mass of the former. It is preferable to do this.

また、本発明において、飲食品として供する方法には例えば下記のような方法が挙げられる。
1)前記した組成物をそのままふりかけとして、又はティーパックやカプセルの中に充填して使用する方法。
2)前記したような組成物に糖類、酸類、塩類及び香料類等を調合して使用する方法。
3)前記したような組成物をベイク品、発酵品、練り製品、乳製品、油脂製品、調味料、菓子等の食品、又はコーヒー、ココア、茶、果実ジュース、野菜ジュース、発酵飲料、清涼飲料等の飲料の製造工程で添加して使用する方法。
Moreover, in the present invention, examples of the method used as a food or drink include the following methods.
1) A method in which the above-described composition is used as a sprinkle or filled in a tea pack or capsule.
2) A method of preparing and using saccharides, acids, salts, fragrances, etc. in the composition as described above.
3) Baking products, fermented products, kneaded products, dairy products, fat products, seasonings, foods such as confectionery, or coffee, cocoa, tea, fruit juice, vegetable juice, fermented beverages, soft drinks, etc. A method of adding and using in the manufacturing process of beverages.

以下実施例を挙げて本発明を更に説明する。   The following examples further illustrate the present invention.

実施例1
ヒメマツタケ培養物(培養菌糸体及び培養濾液)から以下のようにして抽出物を得た。
まず、ヒメマツタケ菌糸体を、グルコース20g、酵母エキス5g、水1Lから成る液体培地(pH5.5)にて、30℃で30日間振盪培養した。遠心分離した菌糸体に7倍量の水を加え、95℃にて2時間加熱抽出し、抽出濾液にエタノールを加えて多糖を沈澱させた。多糖を遠心分離して集め、アセトン次いでエーテルにて洗浄して、菌糸体1g当り21mgの熱水抽出物を得た。複合成分は分子量105〜107(ゲル濾過法)、[α]D+57°(c=2.0、水)、蛋白含量5%、少量のガラクトースとリボースを伴うグルコマンナン蛋白複合体であった。
次に、上で述べた菌糸体を培養して得られた濾液を、1/6容まで減圧濃縮し、これに等容のエタノールを加え、4℃に一夜放置した。生じた沈澱を遠心分離後、アセトンとエーテルで洗浄し、真空乾燥(室温)して、培養濾液1L当り575mgの乾燥物を得た。
乾燥物は分子量105〜107(ゲル濾過法)、[α]D+63°(c=2.0、水)、微量のグルコース、ガラクトース、リボースを含むマンナン蛋白複合体であった。
このようにヒメマツタケ培養物から分離された成分は、いずれもグルコマンナン蛋白複合体であった。
Example 1
An extract was obtained from a Japanese matsutake mushroom culture (cultured mycelium and culture filtrate) as follows.
First, the mycelium of Himematsutake was cultured with shaking at 30 ° C. for 30 days in a liquid medium (pH 5.5) consisting of 20 g of glucose, 5 g of yeast extract, and 1 L of water. Seven times the amount of water was added to the centrifuged mycelium, and the mixture was extracted by heating at 95 ° C. for 2 hours. Ethanol was added to the extracted filtrate to precipitate the polysaccharide. The polysaccharide was collected by centrifugation, washed with acetone and then ether to obtain 21 mg of hot water extract per gram of mycelium. The complex component was a glucomannan protein complex with a molecular weight of 10 5 to 10 7 (gel filtration method), [α] D + 57 ° (c = 2.0, water), a protein content of 5%, and a small amount of galactose and ribose. It was.
Next, the filtrate obtained by culturing the above-mentioned mycelium was concentrated under reduced pressure to 1/6 volume, and an equal volume of ethanol was added thereto and left at 4 ° C. overnight. The resulting precipitate was centrifuged, washed with acetone and ether, and vacuum-dried (room temperature) to obtain 575 mg of dried product per liter of culture filtrate.
The dried product was a mannan protein complex containing a molecular weight of 10 5 to 10 7 (gel filtration method), [α] D + 63 ° (c = 2.0, water), trace amounts of glucose, galactose and ribose.
Thus, all the components isolated from the Japanese matsutake mushroom culture were glucomannan protein complexes.

上記のヒメマツタケ培養物より得られた熱水抽出物は一定の分解点、融点を示さず、強熱により炭化するが、著しく安定である。室温では少なくとも3年間は安定であり、120℃×20分間の滅菌処理を行なっても活性の低下は見られなかった。   The hot water extract obtained from the above-mentioned Japanese matsutake mushroom culture does not exhibit a certain decomposition point and melting point, and is carbonized by ignition, but is extremely stable. At room temperature, it was stable for at least 3 years, and no decrease in activity was observed even after sterilization at 120 ° C. for 20 minutes.

次いで、上記で得た熱水抽出物(乾燥物を含む)50mgと牛グロブリン濃縮物240mgを均一に混合して本発明組成物を得た。   Next, 50 mg of the hot water extract (including the dried product) obtained above and 240 mg of bovine globulin concentrate were uniformly mixed to obtain the composition of the present invention.

実施例2
ヒメマツタケの子実体の細胞壁破壊乾燥物100gに精製水1000mLを加え、緩やかに撹拌しながら水浴上で2時間、熱水抽出した。同一操作を2回繰り返し、2回の熱水抽出液を合わせた後、200mLになるまで減圧濃縮液した。減圧濃縮液に最終エタノール濃度が70%になるまでエタノールを加え、遠心分離して、エタノール沈澱物13.3gを分離した。エタノール沈澱物を固定相としてDEAE−トヨパールゲル(商品名、東洋曹達工業社製)を充填したカラムクロマトグラフィーに供し、フェノール硫酸法により糖の発色がなくなるまで溶出して、溶出画分を分画した。溶出画分を透析した後、凍結乾燥して、熱水抽出物5.6gを得た。得られた熱水抽出物は前記表1〜表4のような組成及び理化学的性質を有していた。
Example 2
Purified water (1000 mL) was added to 100 g of dried cell wall-disrupted fruit bodies of Himematsutake fruiting bodies, and hot water extraction was performed for 2 hours on a water bath with gentle stirring. The same operation was repeated twice, and the two hot water extracts were combined, and then concentrated under reduced pressure to 200 mL. Ethanol was added to the concentrated solution under reduced pressure until the final ethanol concentration reached 70%, followed by centrifugation to separate 13.3 g of ethanol precipitate. The ethanol precipitate was used as a stationary phase and subjected to column chromatography packed with DEAE-Toyopearl Gel (trade name, manufactured by Toyo Soda Kogyo Co., Ltd.). . The eluted fraction was dialyzed and lyophilized to obtain 5.6 g of a hot water extract. The obtained hot water extract had the composition and physicochemical properties as shown in Tables 1 to 4 above.

次いで、上記で得た熱水抽出物100mgと牛グロブリン濃縮物240mgを均一に混合して本発明組成物を得た。   Next, 100 mg of the hot water extract obtained above and 240 mg of bovine globulin concentrate were uniformly mixed to obtain the composition of the present invention.

試験例1
実施例1及び2で得た本発明組成物、実施例1及び2で得られた抽出物、牛グロブリン濃縮物のそれぞれについて経口投与による抗腫瘍作用の確認試験を下記のように行なった。
Test example 1
Each of the compositions of the present invention obtained in Examples 1 and 2, the extracts obtained in Examples 1 and 2 and the bovine globulin concentrate were confirmed by oral administration for confirming antitumor activity as follows.

抗腫瘍試験
5週齢のICR/Slc系雌性マウス10匹を1群として用いた。これに、移植後7日目のマウスから採取したSarcoma 180腫瘍細胞(5×106個)を皮下に移植し、24時間後から各検体の一定量を毎日朝・夕2回連日20日間、胃ゾンデにて強制的に経口投与を行なった。移植21日目に腫瘍の体積(cm3)、(4/3πa2b/2、但し、a:短径mm、b:長径mm)を測定し、対照群と比較して腫瘍抑制率(%)=(1−T/C)×100を算出した。但し、T:検体投与群の腫瘍の体積、C:対照群の腫瘍の体積。また、移植28日目までにおいて腫瘍が完全に消失したマウス数及び当該移植28日後まで生存したマウス数を確認した。その結果は表6のとおりであった。
Anti-tumor test Ten ICR / Slc female mice aged 5 weeks were used as one group. To this, Sarcoma 180 tumor cells (5 × 10 6 cells) collected from mice 7 days after transplantation were subcutaneously transplanted, and a fixed amount of each specimen was obtained twice daily in the morning and evening for 20 days, 24 hours later. Oral administration was forcibly administered with a gastric sonde. On the 21st day of transplantation, the tumor volume (cm 3 ), (4 / 3πa 2 b / 2, where a: minor axis mm, b: major axis mm) was measured, and tumor suppression rate (% ) = (1-T / C) × 100. However, T: Volume of the tumor in the sample administration group, C: Volume of the tumor in the control group. Further, the number of mice in which the tumor completely disappeared by the 28th day after transplantation and the number of mice that survived until the 28th day after the transplantation were confirmed. The results are shown in Table 6.

尚、マウスに対する経口投与実験では、各投与量とも所定の経口投与量がマウスの体重10gあたり、0.2mLになるように生理食塩水で調整し毎日、朝・夕2回、連日20日間胃ゾンデにて強制的に経口投与を行なった。   In an oral administration experiment on mice, each dose was adjusted with physiological saline so that the prescribed oral dose was 0.2 mL per 10 g of the body weight of the mouse. Daily, twice in the morning and evening, every day for 20 days. Oral administration was forcibly performed with a sonde.

Figure 2006028070
Figure 2006028070

表6から明らかな如く、本発明組成物たる試験群(1)及び(3)では、ヒメマツタケの熱水抽出物単独投与群である(2)及び(4)と比較して、腫瘍の完全消失をともなう顕著な抗腫瘍増強効果が認められた。   As is apparent from Table 6, in the test groups (1) and (3) which are the compositions of the present invention, the complete disappearance of the tumor, as compared with the groups (2) and (4) which were administered with the hot water extract alone. A significant antitumor enhancing effect was observed.

動物実験の結果より、人体に薬剤を投与する場合、まず問題になるのはヒトと動物(マウス)との薬剤感受性を考慮する必要がある。そこで本実験では、これまでマウスにおいて抗腫瘍効果の面から有効性が推定された経口投与量に基づき、マウスとヒトの感受性差(Emil J. Freireich et al.:Cancer chemotherapy reports, 50(4), 219, 1966)より、ヒトに対する経口投与量を推測すると、ヒメマツタケの熱水抽出物50〜100mg/60kg(ヒト)に牛グロブリン濃縮物50〜1000mg/60kg(ヒト)の添加するのが好ましい。   From the results of animal experiments, when drugs are administered to the human body, it is necessary to consider the drug sensitivity between humans and animals (mouses). Therefore, in this experiment, the sensitivity difference between mice and humans (Emil J. Freireich et al .: Cancer chemotherapy reports, 50 (4)) , 219, 1966), it is preferable to add 50-1000 mg / 60 kg (human) of bovine globulin concentrate to 50-100 mg / 60 kg (human) of the hot water extract of Himematsutake.

試験例2
表6に記載した試験群(1)[併用群]、試験群(2)[単独投与群]を選択して、牛グロブリン濃縮物添加によるヒメマツタケの抗腫瘍増強効果に対するメカニズムについて検討した。
Test example 2
The test group (1) [combination group] and the test group (2) [single administration group] described in Table 6 were selected, and the mechanism for the antitumor enhancing effect of Japanese matsutake by adding bovine globulin concentrate was examined.

表6記載の全て同一実験条件下において対照群、(1)及び(2)の試験群の各種の免疫担当細胞に対する作用をみることにより、免疫学的メカニズムについて考察した。20日経口投与し、最終投与24時間後にマウスを放血致死させ、脾臓中に存在するL3T4−陽性細胞とアシアロGM1−陽性細胞を伊藤均らの方法(Anti-Cancer Drug Design, 8巻, 193〜202頁, 1993年)によりフロウ・サイトメトリで測定した。その結果は表7のとおりであった。   The immunological mechanism was examined by observing the effects of the control group, (1) and (2) on the various immunocompetent cells under the same experimental conditions listed in Table 6. 20 days after oral administration, the mice were exsanguinated 24 hours after the final administration, and L3T4-positive cells and asialo GM1-positive cells present in the spleen were determined by the method of Hitoshi Ito (Anti-Cancer Drug Design, Vol. 8, 193- 202, 1993), measured by flow cytometry. The results are shown in Table 7.

Figure 2006028070
Figure 2006028070

表7の結果から本発明で用いる熱水抽出物は単独投与においてもL3T4−陽性細胞及びアシアロGM1−陽性細胞の産生抑制に対して賦活作用を示すが、さらに牛グロブリン濃縮物の添加により、より顕著な賦活作用が認められ、表6に示される抗腫瘍効果とよく相関することが確認された。   The results shown in Table 7 show that the hot water extract used in the present invention has an activation effect on the suppression of production of L3T4-positive cells and asialo GM1-positive cells even when administered alone. A remarkable activation effect was observed, and it was confirmed that the antitumor effect shown in Table 6 correlated well.

試験例3
実施例1及び2で得た本発明組成物について、経口投与による急性毒性試験を行なったが、マウスに対するLD50は3000mg/kg超であり、ラットに対するLD50は3500mg/kg超であった。またラットに対する亜急性毒性試験結果及びウサギに対する一般薬理試験結果からも、本発明組成物は毒性に関する問題点を有しなかった。
Test example 3
The composition of the present invention obtained in Examples 1 and 2 was subjected to an acute toxicity test by oral administration. The LD50 for mice was more than 3000 mg / kg, and the LD50 for rats was more than 3500 mg / kg. Further, from the results of subacute toxicity tests on rats and the results of general pharmacology tests on rabbits, the composition of the present invention did not have any problems related to toxicity.

実施例3
実施例1と同様にして熱水抽出液を得た後、該熱水抽出液1kgに、牛グロブリン濃縮物5kg、砂糖100g、蜂蜜15g、カラメル5g、アスコルビン酸0.75g、クエン酸0.3g及びレモン系香料0.2gを添加混合して、本発明健康飲料を得た。
Example 3
After obtaining a hot water extract in the same manner as in Example 1, 5 kg of beef globulin concentrate, 100 g of sugar, 15 g of honey, 5 g of caramel, 0.75 g of ascorbic acid, and 0.3 g of citric acid were added to 1 kg of the hot water extract. And 0.2g of lemon-based fragrances were added and mixed to obtain the health drink of the present invention.

実施例4
実施例1と同様にしてエタノール沈澱物を得た後、該エタノール沈澱物の凍結乾燥物10gに、牛グロブリン濃縮物50g、アスコルビン酸0.5g及びリンゴ搾汁液2kgを添加混合して、本発明リンゴジュースを得た。
Example 4
After obtaining an ethanol precipitate in the same manner as in Example 1, 50 g of beef globulin concentrate, 0.5 g of ascorbic acid and 2 kg of apple juice were added to and mixed with 10 g of the freeze-dried product of the ethanol precipitate. I got apple juice.

実施例5
実施例1と同様にして凍結乾燥した抽出物を得た後、若干量の塩化カルシウム及び第三リン酸ナトリウムと共に該抽出物5gと牛グロブリン濃縮物25gを、採肉して水さらして脱水した後、予冷した魚肉2kgに、そのすりつぶし工程で添加し、凍結して、本発明冷凍すり味を製造した。
Example 5
After obtaining a freeze-dried extract in the same manner as in Example 1, 5 g of the extract and 25 g of bovine globulin concentrate were collected together with some calcium chloride and sodium triphosphate and dehydrated by water exposure. Thereafter, it was added to 2 kg of pre-cooled fish meat in the grinding step and frozen to produce the frozen savory taste of the present invention.

Claims (4)

ヒメマツタケの熱水抽出物と牛グロブリン濃縮物とを含有することを特徴とする抗腫瘍組成物。   An antitumor composition comprising a hot water extract of Japanese matsutake and a bovine globulin concentrate. ヒメマツタケの熱水抽出物が、ヒメマツタケの子実体、ヒメマツタケの子実体の細胞壁破壊物、ヒメマツタケ培養物、ヒメマツタケ培養物の細胞壁破壊物、それらの乾燥物の何れか1種以上から得られたものであることを特徴とする請求項1記載の抗腫瘍組成物。   A hot water extract of Himematsutake was obtained from any one or more of the fruit bodies of Himematsutake, the cell wall destruction of the fruit body of Himematsutake, the culture of Himematsutake, the cell wall destruction of Himematsutake culture, and their dried products. The antitumor composition according to claim 1, wherein 熱水抽出物が、ヒメマツタケの熱水抽出液を減圧濃縮し、次いでエタノールで沈澱処理し、次いで液体クロマトグラフィーで分画処理し、次いで透析した後、凍結乾燥したものであることを特徴とする請求項1又は2記載の抗腫瘍組成物。   The hot water extract is characterized in that the hot water extract of Himematsutake is concentrated under reduced pressure, then precipitated with ethanol, then fractionated by liquid chromatography, then dialyzed and lyophilized. The antitumor composition according to claim 1 or 2. 医薬又は健康食品である請求項1〜3の何れか1項記載の抗腫瘍組成物。   The antitumor composition according to any one of claims 1 to 3, which is a medicine or a health food.
JP2004207988A 2004-07-15 2004-07-15 Antineoplastic composition Pending JP2006028070A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004207988A JP2006028070A (en) 2004-07-15 2004-07-15 Antineoplastic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004207988A JP2006028070A (en) 2004-07-15 2004-07-15 Antineoplastic composition

Publications (1)

Publication Number Publication Date
JP2006028070A true JP2006028070A (en) 2006-02-02

Family

ID=35894843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004207988A Pending JP2006028070A (en) 2004-07-15 2004-07-15 Antineoplastic composition

Country Status (1)

Country Link
JP (1) JP2006028070A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103070388A (en) * 2013-02-04 2013-05-01 云南茂昽生物科技有限公司 Delicate tricholoma matsutake active extract and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115840A (en) * 1984-07-03 1986-01-23 Microbial Chem Res Found Immuno-activating agent
JP2001333731A (en) * 2000-05-25 2001-12-04 Ichimaru Pharcos Co Ltd Food having immunostimulation activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115840A (en) * 1984-07-03 1986-01-23 Microbial Chem Res Found Immuno-activating agent
JP2001333731A (en) * 2000-05-25 2001-12-04 Ichimaru Pharcos Co Ltd Food having immunostimulation activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103070388A (en) * 2013-02-04 2013-05-01 云南茂昽生物科技有限公司 Delicate tricholoma matsutake active extract and preparation method and application thereof
CN103070388B (en) * 2013-02-04 2014-06-04 云南茂昽生物科技有限公司 Delicate tricholoma matsutake active extract and preparation method and application thereof

Similar Documents

Publication Publication Date Title
Mizuno Bioactive substances in Hericium erinaceus (Bull.: Fr.) Pers.(Yamabushitake), and its medicinal utilization
Zhou et al. In vivo growth-inhibition of S180 tumor by mixture of 5-Fu and low molecular λ-carrageenan from Chondrus ocellatus
EP2098240B1 (en) Agent for promoting healing of living body
WO2000062785A1 (en) Remedies
US10967017B2 (en) Traditional Chinese medicine composition and use thereof
JP2004307453A (en) Vascularization inhibitor and use thereof
JP2004315512A (en) Functional composition
KR100711930B1 (en) Ginseng polysaccharides composition having the use of stabilization and propagation of lactic acid bacteria
CN109602759B (en) Application of podocarpus macrophyllus polysaccharide
US11026988B2 (en) Traditional Chinese medicine composition and use thereof
US10967016B2 (en) Traditional Chinese medicine composition and use thereof
JPH07284375A (en) Immune-enhanced food compound mainly of isaria-type &#39;tochu-kaso&#39;
KR20040010732A (en) Black Soybean Polysaccharides
JP2006028070A (en) Antineoplastic composition
JP2000159686A (en) Preparation for lak activity potentiation arising from extract from mycelia of lntinus edodes
JP4261071B2 (en) Therapeutic agent
JPH11302191A (en) Immunoactivator and antitumor agent containing extract from lyophyllum decastes (fr.) sing. as active ingredient
JP6324551B2 (en) Anti-breast cancer agent, food for anti-breast cancer, method for inhibiting breast cancer, and method for producing anti-breast cancer agent
JPWO2006126488A1 (en) Hanabira bamboo extract
JP4931375B2 (en) Antimuscular fatigue agent and food and drink
KR101989980B1 (en) Anticancer or immunactive polysaccharide from residues of immature citrus extract or immature citrus peel and composition comprising the same as an active ingredient
JP2001103927A (en) Method of producing agaricus blazei murill extract having high antitumor activity
JP2019041687A (en) Composition for eating and drinking
JP2007112750A (en) Nitric oxide production inhibitor
KR20070014745A (en) Exo-biopolymer isolated from submerged mycelial culture of grifola frondosa increasing immune activity

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101005

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110301